Detalhe da pesquisa
1.
An International Learning Collaborative Phase 2 Trial for Haploidentical Bone Marrow Transplant in Sickle Cell Disease.
Blood
; 2024 Mar 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38493482
2.
Continuous and differential improvement in worldwide access to hematopoietic cell transplantation: activity has doubled in a decade with a notable increase in unrelated and non-identical related donors.
Haematologica
; 2024 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38721749
3.
Epidemiology of bloodstream infections and the impact of antimicrobial resistance in pediatric hematopoietic cell transplant.
Transpl Infect Dis
; 26(1): e14228, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38180287
4.
High-dose chemotherapy with autologous stem cell transplantation for patients with extracranial germ cell tumors - experience of two Brazilian pediatric centers.
Pediatr Hematol Oncol
; 40(6): 539-553, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36940088
5.
One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donors.
Haematologica
; 107(5): 1045-1053, 2022 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34382386
6.
Outcomes after Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide in Patients with Primary Immunodeficiency Diseases.
Biol Blood Marrow Transplant
; 26(10): 1923-1929, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32653621
7.
The Global State of Hematopoietic Cell Transplantation for Multiple Myeloma: An Analysis of the Worldwide Network of Blood and Marrow Transplantation Database and the Global Burden of Disease Study.
Biol Blood Marrow Transplant
; 26(12): 2372-2377, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32846200
8.
Impact of CD34 Cell Dose and Conditioning Regimen on Outcomes after Haploidentical Donor Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide for Relapsed/Refractory Severe Aplastic Anemia.
Biol Blood Marrow Transplant
; 26(12): 2311-2317, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32949751
9.
Real-World Issues and Potential Solutions in Hematopoietic Cell Transplantation during the COVID-19 Pandemic: Perspectives from the Worldwide Network for Blood and Marrow Transplantation and Center for International Blood and Marrow Transplant Research Health Services and International Studies Committee.
Biol Blood Marrow Transplant
; 26(12): 2181-2189, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32717432
10.
The Impact of Donor Type on Outcomes and Cost of Allogeneic Hematopoietic Cell Transplantation for Pediatric Leukemia: A Merged Center for International Blood and Marrow Transplant Research and Pediatric Health Information System Analysis.
Biol Blood Marrow Transplant
; 26(9): 1747-1756, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32464284
11.
Targeted-dose of busulfan: Higher risk of sinusoidal obstructive syndrome observed with systemic exposure dose above 5000 µMol⸱min. A historically controlled clinical trial.
Hematol Oncol
; 38(5): 773-781, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32779746
12.
Hematopoietic cell transplantation for Diamond Blackfan anemia: A report from the Pediatric Group of the Brazilian Bone Marrow Transplantation Society.
Eur J Haematol
; 105(4): 426-433, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32525237
13.
Hematopoietic cell transplantation in pediatric patients with acute leukemias or myelodysplastic syndrome using unrelated adult or umbilical cord blood donors in Brazil.
Pediatr Transplant
; 24(7): e13789, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32757316
14.
Worldwide Network for Blood and Marrow Transplantation Recommendations for Establishing a Hematopoietic Cell Transplantation Program, Part I: Minimum Requirements and Beyond.
Biol Blood Marrow Transplant
; 25(12): 2322-2329, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31071457
15.
Worldwide Network for Blood and Marrow Transplantation Recommendations for Establishing a Hematopoietic Stem Cell Transplantation Program in Countries with Limited Resources, Part II: Clinical, Technical, and Socioeconomic Considerations.
Biol Blood Marrow Transplant
; 25(12): 2330-2337, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31002990
16.
Allogeneic Bone Marrow Transplants for Pediatric Severe Aplastic Anemia: Real-world Data comparing Matched Related and Unrelated Donors in a Developing Country. Retrospective study on behalf of the Pediatric Hematopoietic Stem Cell Transplant Working Group of the Brazilian Bone Marrow Transplantation Society (SBTMO) and the Brazil-Seattle Consortium (Gedeco).
Pediatr Transplant
; 23(7): e13552, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31297928
17.
Bone Marrow versus Peripheral Blood from Unrelated Donors for Children and Adolescents with Acute Leukemia.
Biol Blood Marrow Transplant
; 24(12): 2487-2492, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30142417
18.
Transplantation of Hematopoietic Stem Cells for Primary Immunodeficiencies in Brazil: Challenges in Treating Rare Diseases in Developing Countries.
J Clin Immunol
; 38(8): 917-926, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30470982
19.
Adherence and immune response to revaccination following hematopoietic stem cell transplantation at a pediatric onco-hematology reference center.
Transpl Infect Dis
; 20(4): e12903, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-29668078
20.
Hematopoietic Stem Cell Transplantation Activity in Pediatric Cancer between 2008 and 2014 in the United States: A Center for International Blood and Marrow Transplant Research Report.
Biol Blood Marrow Transplant
; 23(8): 1342-1349, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28450183